| UCSF Magazine

Parkinson’s Rates Are Surging. Is Exposure to Poisons to Blame?

The upsurge in Parkinson's cases has been described as reaching pandemic levels. Caroline Tanner, MD, PhD, discusses her research, which explains why cases are rising, and what we can do to reduce our risk or slow progression.

UCSF Launches First Public Archive of Firearm Industry Records

UCSF is to become of the repository of a new class of industry documents due to a settlement in the state of Minnesota.

For Early Prostate Cancer ‘Active Surveillance’ Is Now #1 Choice

The number of low and intermediate-risk prostate cancer patients undergoing active surveillance in place of aggressive treatment has tripled to quadrupled over the last 20 years.

Building a Culture of Well-Being: UCSF Earns Gold Recognition

UCSF is celebrating continued recognition for its commitment to supporting the health and well-being of its workforce.

Unexpected Findings Add New Insight on Cannabis and Heart Health

A new trial showed that inhaled cannabis was associated with a statistically significant 9% reduction in ectopic beats, which can sometimes signal a serious heart condition. While this finding wouldn't necessarily influence clinical decisions, it does indicate a need for further study and highlights the complex picture of the effects of cannabis on health.

How to Prepare Young Athletes for a Safe Return to School Sports

Orthopedic surgeon Dr. Nirav Pandya provides insight on how to ensure school-age children are prepared to play fall sports, including how to help them prevent early-season injuries.

Adults Living with HIV Are at High Risk for Diabetes. Here’s Why

UCSF reserachers discover why people with controlled HIV are at much higher risk for diabetes than HIV-negative people.

Chugai and UCSF to Collaborate on Drug Discovery Research

Chugai Pharmaceutical Co., Ltd. and UC San Francisco have entered into a Master Collaboration Agreement to advance drug discovery research. The multi-year agreement establishes a framework to facilitate research collaborations in areas including the exploration of disease biology, the identification of novel drug targets, and the development of new therapeutic approaches. An initial research project is already underway with a UCSF principal investigator.

Can Mini Organs Help Predict Breast Tumors’ Response to Therapy?

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from an innovative clinical trial called I-SPY and rapid experimentation on lab-grown mini tumors.

The advance could hasten more personalized treatments for breast cancer, including the triple negative type, which is especially aggressive and hard to treat.

UCSF’s New Bakar Research and Academic Building Is Inspired by Fog

Subscribe to